Blood products
Ended Awarded Last action
- Contract number
- W81K0225FA030
- Awardee
-
The Republic Of Korea National Red Cross UEI PWQUAWD9VUF3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $9,267
Award facts
- Contract value 100% obligated
- $9,267.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $74 | |
| Original award | $9,193 |
About this award
The Defense Health Agency awarded a $9,267.40 firm-fixed-price Blanket Purchase Agreement (BPA) call to The Republic of Korea National Red Cross, operating as Gyeonggi Blood Center Red Cross, for the provision of blood products. This call order, issued on April 1, 2025, with an ultimate completion date of June 30, 2025, represents a continuation of the organization's single-award BPA valued at $249,000 and established for the five-year performance period from July 1, 2022 through June 30, 2027. No set-aside designation was applied to this award. Performance will occur entirely at the contractor's facilities in Suwon, Gyeonggi-do, South Korea, supporting U.S. military healthcare operations in the region.
The Gyeonggi Blood Center Red Cross specializes in procuring and delivering critical blood components, including apheresis platelets in 250-milliliter units, whole blood units, and other essential blood products tailored to military healthcare requirements. These supplies support Department of Defense medical facilities, including the Brian Allgood Army Community Hospital and other facilities serving U.S. personnel stationed in South Korea. The contractor has maintained a consistent track record of providing blood products exclusively to the Defense Health Agency and U.S. Army Medical Command since establishing its SAM registration in October 2021, with individual call orders typically ranging from approximately $2,475 to $12,000 to meet ongoing operational blood inventory needs.
Quick answers
Who was awarded contract W81K0225FA030?
W81K0225FA030 was awarded to The Republic Of Korea National Red Cross by Medical Command (Department of the Army) on April 1, 2025.
How much is contract W81K0225FA030 worth?
The government has obligated $9,267 on W81K0225FA030.
Which agency awarded contract W81K0225FA030?
Medical Command (Department of the Army) awarded W81K0225FA030, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0225FA030 an order under another contract?
Yes. W81K0225FA030 is a BPA call under W81K0222A0009, a blanket purchase agreement.
Was contract W81K0225FA030 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award